US Stock MarketDetailed Quotes

CELC Celcuity

Watchlist
  • 12.710
  • +0.170+1.36%
Close Dec 4 16:00 ET
  • 12.710
  • 0.0000.00%
Post 16:02 ET
471.92MMarket Cap-4888P/E (TTM)

About Celcuity Company

Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Company Profile

SymbolCELC
Company NameCelcuity
Listing DateSep 20, 2017
Issue Price9.50
Founded2012
CEOMr. Brian F. Sullivan
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address16305 36th Avenue North,Suite 100
CityMinneapolis
ProvinceMinnesota
CountryUnited States of America
Zip Code55446
Phone1-763-392-0767
Websitehttp://www.celcuity.com

Company Executives

  • Name
  • Position
  • Salary
  • Brian F. Sullivan
  • Chairman of the Board and Chief Executive Officer
  • 1.74M
  • Dr. Lance G. Laing
  • Director, Chief Science Officer, Vice President and Secretary
  • 1.48M
  • Vicky Hahne
  • Chief Financial Officer and Principal Accounting Officer
  • 898.74K
  • Richard J. Nigon
  • Independent Director
  • 87.50K
  • David F. Dalvey
  • Independent Director
  • 87.50K
  • Dr. Leo T. Furcht, M.D.
  • Independent Director
  • 87.50K
  • Dr. Richard E. Buller, M.D.,PhD
  • Independent Director
  • 87.50K
  • Dr. Polly A. Murphy, D.V.M.,PhD
  • Independent Director
  • 87.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data